COMMUNICATIONS
1983; Wiley; Volume: 78; Issue: S1 Linguagem: Francês
10.1111/j.1476-5381.1983.tb17360.x
ISSN1476-5381
Tópico(s)Nicotinic Acetylcholine Receptors Study
ResumoBritish Journal of PharmacologyVolume 78, Issue S1 p. 1P-87P Free Access COMMUNICATIONS First published: March 1983 https://doi.org/10.1111/j.1476-5381.1983.tb17360.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References Davies, J. (1982). Br. J. Pharmac. 76, 473– 481. Sayers, A.C. et al., (1980). Drug Res. 30, 793– 803. Davidoff, R.A. et al., (1967). J. Neurochem. 14, 1025– 1031. Davies, J. (1982). Br. J. Pharmac. 76, 473– 481. Davies, J. & Johnston, S.E. (1983). Pharmac. Soc. Commun, this meeting. Aghajanian, G.K. et al. (1977) Brain Res. 136, 570– 577. Carlen, P.J. & Durand, D. (1981) Neuroscience 6, 839– 846. Cedarbaum, J.M. & Aghajanian, G.K. (1977) Eur.J. Pharmac. 44, 375– 385. Henderson, G. et al. (1982) Exp.Brain Res. 45, 29– 37. Andrade, R. & Aghajanian, G.K. (1981) Soc.Neurosci. Abstr. 7, 573. Govoni, S. et al., (1980) J.Pharmac.exp.Ther. 215, 413– 417. Kalivas, P.W. et al., (1981) Brain Res. 229, 525– 529. Kitabgi, P. et al., (1980) Molec. Pharmac. 16, 11– 19. Palacios, J.M. & Kuhar, M.J. (1981) Nature, 294, 587– 589. Creese, I. & Snyder, S.H. (1979) Eur.J.Pharmac. 56,277. Hall, M.D. et al. (1981) Neurosci.Lett.Weled Suppl. 7,5363. Nagy, J.E. et al. (1978) Nature 274, 278. Reisine, T.D. et al. (1979) Brain Res. 169,209. Schwarcz, R. et al. (1978) Nature 271, 766. Bowery, N.G., Hill, D.R. & Hudson, A.L. (1982). Br. J. Pharmac. in press. Hill, D.R. & Bowery, N.G. (1981). Nature (Lond.) 290, 149. Shoulson, I. (1982). “Excitotoxins”, Wenner-Gren Center Symposium 39, eds K. Fuxe, R. Schwarcz & P.J. Roberts Pergamon. in press. Zukin, S.R., Young, A.B. & Snyder, S.H. (1974). Proc. Natl. Acad. Sci. USA. 71, 4802– 4807. Carson, S. (1982) Biochem. Pharmac. 31, 1806. Davis, A. et al. (1981) Eur. J. Pharm. 70, 321. Gorissen, H. & Laduron, P. (1979) Nature, 279, 272. Hulme, E.C. et al. (1982) J. Receptor Res. (in press). Lerner, N.H. et al. (1981) Life Sci. 29, 2367. Owen, F.O. et al. (1978) Lancet ii, 223. Gray, E.G. & Whitaker, V.P. (1962) J. Anat. (Lond.) 96, 79. Iversen, L.L. (1975) Handbook of psychopharmacology 3, 381. Wood, M.D. and Wyllie, M.G. (1982) Neuropharmac. 21, 375. Garcha, H.S., Kumar, R., Pratt, J.A. & Stolerman, I.P. (1982) Br.J.Pharmac. 76, Proc. Suppl., 227P. Romano, C. & Goldstein, A. (1980) Science, 210, 647– 650. Rosecrans, J.A, & Chance, W.T. (1977) Discriminative stimulus properties of drugs. H. Lal, ed. Plenum, New York, pp. 155– 185. Stolerman, I.P. & D'Mello, G.D. (1981) Psychopharmacology, 73, 295– 303. Al Shabibi, U.M.H. and Dogget, N.S. (1978) J. Pharm. Pharmac. 30, 529. Dedek, J. et al. (1982) Br. J. Pharmac., 77, supt., 361P. Dettmar, P.W. et al. (1981) Br. J. Pharmac., 74, 843 P. Langer, S.Z. (1980) Pharmacol. Rev. 32, 337– 362. Scatton, B. et al. (1980) J. Pharmacol. Exp. Ther. 215, 494. Worms, P. and Lloyd, K.G, (1979) Pharmac. Ther. 5, 445. Ashcroft, G.W. et al. (1981) Br. J. Psychiatry. 138, 268– 269. Makanjuola, R.O.A. et al. (1977) Psychopharmacology. 55, 67– 74. Dyck, L.E. (1978) Neurochem Res. 3: 775– 791. Jones, R.S.G. (1982) Neuropharmacology 21: 511– 520. Jones, R.S.G. and Broadbent, J. Neuropharmacology 21: in press. Irons J. et al. (1982) Br.J.Pharmac. (in press). Jones R.S.G. (1981) Br.J.Pharmac. 73, 485– 494. Marsden C.A. and Curzon G. (1979) Neuropharmacol. 18, 159– 164. Saavedra and Axelrod J. (1973) J.Pharmacol.exp.Ther. 185, 523– 529. Zambotti F. et al. (1973) Life Sci. 17, 1663– 1670. Curzon, G. & Green, A. R. (1970) Br. J. Pharmac. 39, 653. Greengrass, P. M. & Tonge, S. R. (1972) Br. J. Pharmac. 46, 533P. Yonnone, M. E. et al. (1968) Am. J. Obst. Gyn. 101, 1058– 61. De Belleroche, J.S. & Neal, M.J. 1982 Neuropharmacology 21, 529– 537. Kerwin, R.W. & Pycock, C.J. 1979 Neurosci., 4, 1359– 1365. Murugaiah, K. et al. 1982. Nature 296,570–572. Arbilla et al. (1981), Br. J. Pharmac. 74: 901P. Hertting et al. (1980), Naunyn Schmiedeberg's Arch. Pharmacol 315: 111– 117. Levine, J. et al. (1980) Adv. Biochem. Psychopharmacol. 20, 483– 493. Svendsen, O. & Aaes-Jorgensen, T. (1979) Acta Pharmacol. Toxicol. 45, 352– 378. Waddington, J.L. & Gamble, S.J. (1980) Eur. J. Pharmacol. 68, 387– 388. Waddington, J.L. & Gamble, S.J. (1981) Lancet i, 1375–1376. Waddington, J.L. et al. (1982) In: Advances in Dopamine Research, eds. M. Kohsaka et al., Pergamon, Oxford, 143– 146. Wistedt, B. et al. (1981) Lancet i, 1163. Bliss, T.V.P. and Lømo, T. (1973) J.Physiol. 232, 331. Collingridge, G. et al. (1982) J.Physiol. 327, 83P. Davies, J. and Watkins, J.C. (1982) Brain Res. 235, 378. Dolphin, A.C. et al. (1982) Nature 297, 496. Dunwiddie, T. et al. (1978) Brain Res. 150, 413. Koerner, J.F. and Cotman, C.W. (1981) Brain Res 216, 192. Curtis, D.R. et al. (1971) Brain Res. 33, 57– 73. Frederickson, R.C.A. et al. (1978) Brain Res. 145, 117– 126. Simmonds, M.A. (1980) Neuropharmacology 19, 39– 45. Simmonds, M.A. (1982) Eur. J. Pharmac. 80, 347– 358. Sonnhof, U. et al. (1975) Brain Res. 100, 327– 341. Bedard, P. & Pycock, C. (1977). Br.J.Pharmac. 59, 150P. Jacobs, B.L. (1976). Life Sci. 19, 777. Loveless, A.H. & Maxwell, D.R. (1965). Br.J.Pharmac.Chemother. 25, 158. Johnston, J.P. (1968). Biochem.Pharmac. 17, 1285. Juhasz, L. & Dairman, W. (1977) Fed. Proc. 36, 377. Lippa, A.S. & Regan, B. (1977) Life Sci. 21, 1779. Bellet, M. et al. (1980) Br.J.Pharmac. 71, 365– 369. Brown, M.J. et al. (1981) Clin.Sc1. 61, 591– 598. Lang, R.E. et al. (1982) Clin.Exp.Hyper — Theory and Practice A4 (1–2), 249– 269. Van Loon, G.R. et al. (1981) Neuroendocrinology 33, 153– 157. Arunlakshana, O. & Schild, H.O. (1959) Br. J. Pharmac. 14, 48– 58. Brown, N.L. & Worcel, M. (1982) Br. J. Pharmac. 76, 204P. Minneman, K.D. et al. (1979) J. Pharmacol. Exp. Ther. 211, 502– 508. Yabuuchi, Y. (1977) Br. J. Pharmac. 61, 513– 521. Sassolas, A. et al. (1981) J. Cardiovasc. Pharmacol. 3, 1008. Chapleo, C.B., et al. (1981) Br. J. Pharmacol. 74, 842P. Conway, E.L. and Jarrott, B. (1982) Clin, and Exper. Hyper. 8, 1323– 1334. Parker, M. and Atkinson, J. (1982) Gen. Pharmacol. 13, 79– 85. Shepperson, N. et al. (1981) Naunyn-Schmiedeberg's Arch. Pharmacol., 317, 1– 4. U'Prichard, D.C. et al. (1977) Mol. Pharmacol. 13, 454– 473. Angus, J.A. & Korner, P.I. (1980) Nature 286, 288. Webb, R.C. et al. (1981) Hypertension 3, 93. Langer S.Z. (1974) Biochem.Pharmac. 23, 1793. Starke, K. (1977) Rev.Physiol.Biochem.Pharmac. 77, 1. Boudot, J.P. et al. (1979) Br.J.Pharmac. 63, 445P. Cavero, I. & Lefèvre-Borg, F. (1983) This meeting. E.F. Smith III is a fellow of the Alexander von Humboldt-Stiftung, Bonn, W.Germany. Ritchie, D.M. et al. (1979) Cardiovasc. Res. 13, 199. Schrör, K. et al. (1981) J. Pharmacol. Exp. Ther. 219, 243. Smith, E.F. et al. (1982) Eur. J. Pharmacol. 77, 153. Casagrande, C. et al., 7th International Symposium on Medicinal Chemistry, Torremolinos, Spain, Sept. 1980. Flynn, S.B. et al., (1978) J. Pharmac. Meth., 1, 183– 195. Merlo, F. et al., Symposium on Dopamine Receptor Agonists, Stockholm, Sweden, April, 1982. Au, T.L.S. et al. (1979) Prostaglandins 18, 707– 720. Coker, S.J. et al. (1982) Br. J. Pharmac. 76, 347– 354. Coker, S.J. & Parratt, J.R. (1981) Br. J. Pharmac. 74, 155– 159. Cosnier, D. et al. (1977) Arch. Int. Pharmacodyn. 225, 133. Kane, K.A. and Winslow, E. (1980) J. Cardiovasc. Pharmacol. 2, 193. Vogel, S. et al. (1979) Clin. Res. 27, 212A. Collier, J.G. & Pitcher, D.N. (1980) Br. J. Clin. Pharmacol., 10, 567– 571. Lund-Johansen P. & Omvik, P. (1982) J. Cardiovasc. Pharmacol., 4, 1012– 1017. Taylor, E.M. et al. (1981) J. Cardiovasc. Pharmacol., 3, 337– 368. Broitman, S.A. et al. (1967) J.Lab.Clin.Med. 70, 9– 15. Rogers, A.I. et al. (1968) Digestion 1, 159– 164. Schultz, S.G. (1977) Am.J.Physiol. 233, E249– E254. Bayer, R., Ehara, T. (1978) Prog. Pharmac., 2, 31– 37. Cohen, I., Noble, D., Ohba, M. & Ojeda, C. (1979). J. Physiol. 297, 163– 185. McLaughlin, S. (1973). Nature, 243, 234– 236. Spedding, M. (1982a). Naunyn-Schmiedeberg's Arch. Pharmacol., 318, 234– 240. Spedding, M. (1982b). Br. J. Pharmac., 75, 25P. Drew, G.M. & Whiting, S. B. (1979) Br. J. Pharmac. 67, 207– 215. McGrath, J.C. (1982) Biochem. Pharmac. 31, 467– 484. Timmermans, P.S.M.W.H. & van Zwieten, P.A. (1981) J. Auton. Pharmac. 1, 171– 183. Seely, J.F. & Dirks, J.H. (1977) Kidney Internat. 11, 1– 8. Walter, S.J. et al. (1979) Clin. Sci. 57, 427– 434. Campbell et al. (1979) Arch. Environ. Hlth. 34, 439– 443. Derkx et al. (1982) Br. J. Pharm, (in press). Goldman et al. (1981) J. Lab. Clin. Med. 97, 251– 263. McAllister et al. (1971) Arch. Intern. Med. 127, 919– 923. Baker, S. & Marshall, I. (1982 a) Br. J. Pharmac. 75, Proc. Suppl., 155P. Baker, S. & Marshall, I. (1982 b) Br. J. Pharmac. 76, Proc. Suppl., 212P. Chapleo, C.B. et al. (1981) Br. J. Pharmac. 74, 842P. Kalsner, S. (1979) Br. J. Pharmac. 66, 343. Campbell, I.C. & McKernan, R.M. (1982) Br.J.Pharmac. 75, Proc. Suppl., 100P. Green, A.R. et al. (1982) Br.J.Pharmac. 75, Proc. Suppl., 33P. Smith, C.B. et al. (1981) Brain Res. 210, 413– 418. Smith, C.B. et al. (1982) In: Briley, M et al “New Vistas in Depression” pergamon Press, Oxford. Sugrue, M.F. (1981) Br.J.Pharmac. 74, 760P– 761P. Waldmeier, P.C. et al. (1981) In: Youdim, M.B.H. & Paykel, E.S. “Monoamine Oxidase Inhibitors — The State of the Art” Wiley, Chichester. Youdim, M.B.H. & Finberg, J.P.M. (1982) In: Grahame-Smith, D.G. et al “Psychopharmacology, Excerpta Medica, Amsterdam. Shepperson, N.B. et al. (1981) J. Pharm. Exp. Ther. 219, 540– 546. Timmermans, P.B.M.W.M. et al. (1980) J. Auton. Pharmac. 1, 53– 60. Wietzell, R. et al. (1979) Naunyn Schmiedebergs Arch. Pharmacol. 308, 127– 136. Hamilton, C.A. et al. (1982) Br. J. Pharmac. 75, 417– 424. Majewski, H. et al. (1982) Naunyn-Schmiedeberg's Arch. Pharmac. 321, 20– 27. Starke, K. (1977) Rev. Physiol. Biochem. Pharmac. 77, 1– 124. Chapleo, C.B. et al., (1981), Br. J. Pharmacol. 74, 842P. Medgett, I.C. & Rand, M.J. (1981), Clin. Exp. Pharmacol. Physiol., 8, 503– 507. Cavero, I. et al. (1979) Br.J.Pharmac. 67, 283– 292. Docherty, J.R. & McGrath, J.C. (1980) Naunyn-Schmiedeberg's Arch. Pharmac. 312, 107– 116. Kobinger, W. & Pichler, L. (1980) Eur.J.Pharmac. 65, 393– 402. Fredrickson RCA et al. (1977), SCIENCE 198 756– 758. Naber D. et al. (1980), NEUROSCI. LETT. 21 45– 50. Rosenfeld JP and PE Rice (1979), PHYSIOL. BEHAV. 29 419– 420. Wesche DL and RCA Fredrickson (1981), LIFE SCI 29 2199– 2055. Skingle, M. et al. (1982) Life Sciences 11, 1123– 1132. Tyers, M.B. (1980) Br.J.Pharmac., 69, 503– 512. Gormley, J.J. et al. (1982) Life Sciences (in the press). Shaw, J.W. et al. (1982) Life Sciences (in the press). Slater, P. et al. (1980) J. Pharmac. Methods 3, 39– 49. Wei, E. (1973) Psychopharmac. 28, 35– 44. Wheeler, H. (1982) Neuropharmac. (in the press). Becker, E.L. et al. (1981) Biochemistry of the acute allergic reactions, A.R. Liss New York. Piper, P.J. & Samhoun, M.N. (1981) Prostaglandins 21, 793– 803. Waddell, K.A. et al. (1982) Biochem. Soc. Trans. in press. Ducharme, D.W. et al. (1968) J. Pharmacol. Exp. Ther. 160: 1– 10. Moncada, S. et al. (1977) Thromb. Res. 11: 323– 344. Weksler, B.B. et al. (1977) Proc. Natl. Acad. Sci. 74: 3922– 3926. Chang, D.G-B. & Tai, H.H. (1982) Prost, leuk. med. 8, 11. Moore, P.K. & Hoult, J.R.S. (1978) Biochem. Pharmacol. 27, 1839. Moore, P.K. & Hoult, J.R.S. (1982) Biochem. Pharmacol. 31, 969. Dong, Y.J. & Jones, R.L. (1982) Br.J.Pharmac. 76, 149– 155. Massele, A.Y. & Senior, J. (1981) Br.J.Clin.Pharmac. 12, 285P. Berry, C.N. et al. (1982) Br. J. Pharmac. 75, Proc. Suppl. 7P. Hellewell, P.G. et al. (1980) Eur. J. Pharmacol. 68, 509– 511. Moore, P.K. & Hoult, J.R.S. (1980) Nature 288, 271– 273. Bradshaw, D. et al. (1982) Communication to the British Pharmacological Society, September 1982. Meacock, S.C.R. et al. (1979) Eur. J. Rheumatol. Inflamm. 4, 23– 28. Meacock, S.C.R. and Kitchen, E.A. (1979) J. Pharm. Pharmac. 31, 366– 370. Cashin, C.H. et al. (1979) Agents Actions 9, 553– 559. Lotan, R. (1980) Biochim. Biophys. Acta. 605, 33– 91. Raisman R. et al. (1982) Psychopharmacology 75, 368. Langer S.Z. et al. (1981) Life Sci. 29, 211. Stanley M. et al. (1982) Science 216, 1337. Pearce, F.L. (1982) Klinische Wchschrft., in press. Pearce, F.L. (1981) Agents and Actions 11, 51– 54. Barber HE, et al. (1982). Br. J. Pharmac., in press. Gillespie JS, et al. (1970). Br. J. PHarmac, 40, 257– 267. Smith KJ, et al. (1982). Clin. Sci., 63, 5P. Somogyi A. and Gugler R. (1982). Clin. Pharmacokin., 7, 23– 41. Wilkinson GR and Shand DG. (1975). Clin. Pharmac. Ther., 18, 377– 390. Barber, H.E. et al. (1982a) Br. J. Pharmac. in press. Barber, H.E. et al. (1982b) Br. J. Pharmac. 76, 224P. Gillespie, J.S. and Muir, T.C. (1967) Br. J. Pharmac. 30, 78– 87. Schneider, R.E. and Bishop, H. (1979) Br. J. Clin. Pharmac. 8, 43– 47. Wilkinson, G.R. and Shand, D.G. (1975) Clin. Pharmac. Ther. 18, 377– 390. Al-Dabbagh et al. (1981) J. Pharm. Pharmac. 33, 161–164 (1981). Kahn, et al. Proceedings of the British Pharmacological Society, Dec. 1981. Smith, et al. (1980) Environmental chemicals, enzyme function and human disease (Ciba Foundation Symposium, 1979) 219–244, Excepta Medica. Grabowski, P.S. et al., (1982) B.P.S. Meeting Sunderland. Maggs, J.L. et al., (1982) Xenobiotica, in press. Williams, M.C. and Goldzieher, J.W. (1980) Steroids 36, 255. Adlercreutz, H. et al. (1976) J. clin. Endocr. Metab. 43, 497– 505. Back, D.J. et al. (1981) J. Steroid Biochem. 14, 347– 356. Eriksson, H. (1971) Eur. J. Biochem. 19, 416– 423. Schwenk, M. et al. (1981) Arzneim-Forsch/Drug Res. 31, 1254– 1257. Caspary, W.F. & Graf, S. (1979) Res.Exp.Med. 175, 1– 6. Jenkins, D.J.A. & Taylor, R.H. (1982) Proc.1st.Int.Symp.Acarbose, 86–96. Puls, W. et al. (1980) Frontiers Horm.Res. 7, 235– 47. Truscheit, E. et al. (1981) Angew.Chem. (Int.Ed.) 20, 744. Birdsall, N.J.M., Hulme, E.C. & Burgen, A.S.V. (1980) Proc.R.Soc.Lond.B. 1–12. Bers, D.M. & Langer, G.A. (1979) Am. J. Physiol., 237, 332– 341. Hagiwara, S. & Byerly, L. (1981) Ann. Rev. Neurosci. 4, 69– 125. Hulme, E.C., Birdsall, N.J.M., Burgen, A.S.V. & Mehta, P. (1978) Molec. Pharmac. 14, 737– 750. Barlow, R.B., Berry, K.J., Glenton, P.A.M., Nicolaou, N.M. & Soh, K.S. (1976) Brit. J. Pharmac., 56, 613– 620. Birdsall, N.J.M., Hulme, E.C. & Burgen, A.S.V. (1980) Proc.R.Soc.Lond.B. 207, 1– 12. Berrie, C.P., Birdsall, N.J.M., Burgen, A.S.V. & Hulme, E.C. (1979) B.B.R.C. 87, 1000– 1005. Arunlakshana, O. & Schild, H.O. (1959) Br.J.Pharmac. Chemother. 14, 48– 58. Gaddum, J.H. & Picarelli, Z.P. (1957) Br.J.Pharmac. Chemother. 12, 323– 328. Ireland, S.J. et al. (1982) Br.J.Pharmac. 72, Proc. Suppl. 16P. Langer, S.Z. & Trendelenburg, U. (1969) J.Pharmac.Exp.Ther. 169, 117– 142. Ross, S.B. (1982) In “Biology of Serotonergic Transmission” ed. N.N. Osbourne pp 159– 195. Hammer, R. & Giachetti, A. (1982) Life Sci. 31, 2991. Langer, S.Z. et al. (1981) Hypertension 3, supp. I, 1– 112. Wilffert, B. et al. (1982a) J.Pharmac.Exp. Ther. 221, 762. Wilffert, B. et al. (1982b) J.Pharmac.Exp.Ther. 223, 219. Yamaguchi, I. & Kopin, I.J. (1980) J.Pharmac.Exp.Ther. 214, 275. Ambache, N. et al.. (1974) Br. J. Pharmac., 52, 175. Drew, G.M. & Hilditch, A. (1982) Br. J. Pharmac. 75, 145P. Hilditch, A. & Drew, G.M. (1981) Eur. J. Pharmac., 72, 287. Gibson, A. & Tucker, J.F. (1982) Br. J. Pharmac. in press. Gibson, A. & Wedmore, C.V. (1981) J. Auton. Pharmac. 1, 225– 233. Barnett, D.B. et al. (1978) Nature 273, 166– 168. Brodde, O.-E. et al. (1981) Life Sciences 29, 2189– 2198. Engel, G. et al. (1981) Arch. Pharmacol. 317, 277– 285. Kent, R.S. et al. (1980) Molec. Pharmacol. 17, 14– 23. Minneman, K.P. et al. (1981) Annu. Rev. Neurosci. 4, 419– 461. Chen, Y-C and Prusoff, W.H. (1973). Biochem. Pharmac. 22, 3099. Cotterell, D.J., Munday, K.A. and Poat, J.A. (1982). Brit. J. Pharmac. 76, 36P. Levens, N.R., Munday, K.A., Parsons, B.J., Poat, J.A. and Stewart, C. (1979) J. Physiol. 286, 351. Wilson, T.H. and Wiseman, G. (1954). J. Physiol. 123, 116. Lai, H. & Shearman, G.T. (1981) Drug Dev. Res. 1, 37– 41. Nakaki, T. et al. (1982) J. Pharmac. exp. Ther. 220, 637– 641. Szobor, A. (1962) Psychiat.Neurol.Basel, 143, 178– 196. Tiller, J.R. et al. (1968) Brit.Med.J. 4, 407– 411. Magos, L. & Jarvis, J.A.E. (1970) Br.J.Pharmacol. 39, 26– 33. Bowling, A.C. & deLorenzo, R.J. (1982) Science 216, 1247– 1249. deLorenzo, R.J. et al. (1981) Science 213, 546– 548. File, S.E. (1982) Pharmac. Biochem. Behav. 17, in press. File, S.E. et al. (1982) Neuroscience Letters, in press. File, S.E. & Lister R.G. (1983) This meeting. Anderson, P. et al. (1964) J. Neurophysiol. 27, 608– 619. Ben-Ari, Y. et al. (1979) Can. J. Physiol. Pharmacol. 57, 1462– 1466. Braestrup, C. and Nielsen, M. (1981) Nature (Lond.) 294, 472– 474. Jones, B.J. and Oakley, N.R. (1981) Br. J. Pharmacol. 74, 884P. Pole, P. et al. (1981) Brain Research 217, 216– 220. Donaldson, K.M. & Main, I.H.M. (1981). Br. J. Pharmac. 74, 970P. Main, I.H.M. & Pearce, J.P. (1978). J. Pharmac. Methods 1, 27– 38. Main, I.H.M. & Whittle, B.J.R. (1975). Br. J. Pharmac. 53, 217– 224. Whittle, B.J.R. et al., (1980). Nature 284, 271– 273. Engberg, G. et al. (1981) Nature (London) 293, 222– 223. Hawcock, A.B. et al. (1982) Eur. J. Pharmacol. 80, 135– 138. Leander, S. et al. (1981) Nature (London) 294, 267– 269. Lee, B.E.B. et al. (1982) N.S. Arch. Pharmacol. 318, 281. Rosell, S. and Folkers, K. (1982) T.I.P.S., 3, 21– 212. Nachshen, D.A. & Blaustein, M.P. (1979) Mol. Pharmacol. 16, 579– 586. West, R.E., Jr. et al. (1982) Life Sci. in press. Ferry, D.R. and Glossmann, H. (1982) Naunyn-Schmied. Arch. Pharmac. (in press). Nagao, T. et al. (1972) Japan. J. Pharmac. 22, 467. Towart, R. and Kazda, S. (1979) Br. J. Pharmac. 67, P409. Peters, J.R. and Grahame-Smith, D.G. (1980) Eur J Pharmacol 68, 243. Hunter, W.M. & Greenwood, H. (1962). Nature 194, 485–496. Leysen, J.E. et al. (1982). Mol.Pharmacol. 21, 301– 314. Peroutka & Snyder, S.N. (1979). Mol.Pharmacol. 16, 687– 699. Troxler, F. & Hofmann, A. (1957). Helv.chim.Acta 40, 2160. Dixon, M. et al., (1980) Br. J. Pharmac. 70, 11– 13. Paintal, A.S. (1955) Q. J. exp. Physiol. 40, 89– 111. Widdicombe, J.G. (1974) Rec. Adv. Physiol. 9, 239– 278. Bowman, W.C. (1980) Anesth. Analg. 59, 935– 943. Gibb, A.J. & Marshall, I.G. (1982) Br. J. Pharmac. 76, 187P. Magleby, K.L. et al. (1981) J. Physiol. 312, 97– 113. Volume78, IssueS1March 1983Pages 1P-87P ReferencesRelatedInformation
Referência(s)